(Q37463223)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19400764%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

review article

1 reference

title

Antifungal drug resistance mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19400764%20AND%20SRC:MED&resulttype=core&format=json

antifungal drug resistance

26 January 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19400764%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

3

Ana Espinel-Ingroff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19400764%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Emilia Cantón

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19400764%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

1 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19400764%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19400764%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19400764%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19400764%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

453-460

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19400764%20AND%20SRC:MED&resulttype=core&format=json

When primary antifungal therapy fails

26 January 2020

cites work

1 reference

Has antifungal susceptibility testing come of age?

21 January 2018

1 reference

Antifungal agents: mechanisms of action

21 January 2018

1 reference

Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy

21 January 2018

1 reference

Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses stu

21 January 2018

1 reference

Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.

21 January 2018

1 reference

Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing

21 January 2018

1 reference

Multiple resistance mechanisms to azole antifungals in yeast clinical isolates.

21 January 2018

1 reference

Molecular aspects of azole antifungal action and resistance

21 January 2018

1 reference

Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole.

21 January 2018

1 reference

Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate

21 January 2018

1 reference

A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus

21 January 2018

1 reference

In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance

21 January 2018

1 reference

Update on antifungal drug resistance mechanisms of Aspergillus fumigatus

21 January 2018

1 reference

Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs

21 January 2018

1 reference

A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.

21 January 2018

1 reference

Rapid detection of triazole antifungal resistance in Aspergillus fumigatus

21 January 2018

1 reference

In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp

21 January 2018

1 reference

Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus

21 January 2018

1 reference

Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma

21 January 2018

1 reference

Caspofungin: the first in a new class of antifungal agents

21 January 2018

1 reference

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

21 January 2018

1 reference

Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase

21 January 2018

1 reference

Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis

21 January 2018

1 reference

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis

21 January 2018

1 reference

Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient

21 January 2018

1 reference

Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy

21 January 2018

1 reference

Emergence of Candida tropicalis resistant to caspofungin

21 January 2018

1 reference

Development of candidemia on caspofungin therapy: a case report.

21 January 2018

1 reference

Increasing incidence of Candida parapsilosis candidemia with caspofungin usage

21 January 2018

1 reference

Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain

21 January 2018

1 reference

A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility

21 January 2018

1 reference

Significant differences in drug susceptibility among species in the Candida parapsilosis group

21 January 2018

1 reference

Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility

21 January 2018

1 reference

Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii.

21 January 2018

1 reference

Echinocandins for candidemia in adults without neutropenia

21 January 2018

1 reference

Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.

21 January 2018

1 reference

Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility

21 January 2018

1 reference

In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance

21 January 2018

1 reference

Caspofungin activity against clinical isolates of fluconazole-resistant Candida

21 January 2018

1 reference

Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates

21 January 2018

1 reference

Resistance to echinocandin-class antifungal drugs

21 January 2018

1 reference

Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints

21 January 2018

1 reference

Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment

21 January 2018

1 reference

The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans

21 January 2018

1 reference

Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins

21 January 2018

1 reference

Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin

21 January 2018

1 reference

Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin

21 January 2018

1 reference

A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus

21 January 2018

1 reference

Flucytosine monotherapy for cryptococcosis.

21 January 2018

1 reference

Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi

21 January 2018

1 reference

Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.

21 January 2018

1 reference

Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth

21 January 2018

1 reference

A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes

21 January 2018

1 reference

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

21 January 2018

1 reference

Potential basis for amphotericin B resistance in Aspergillus terreus

21 January 2018

1 reference

Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.

21 January 2018

1 reference

Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.

21 January 2018

1 reference

Susceptibility patterns and molecular identification of Trichosporon species

21 January 2018

1 reference

Invasive aspergillosis in 2002: an update

21 January 2018

1 reference

Multi-azole resistance in Aspergillus fumigatus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.09.18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19400764%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference